United States expected to approve low-cost AstraZeneca/Oxford vaccine in April: Report
Moncef Slaoui, the chief advisor to Operation Warp Speed, the military-led US effort for vaccines, told reporters that US trials and assessments would be complete for approval “sometime in early April.”











